The FDA expanded Casgevy, the first CRISPR gene therapy, to children as young as two. The edit takes hours. The conditioning takes everything. To g...
A Gallup poll released July 7 found the U.S. obesity rate has dropped to 36.4 percent, down 3.5 points from its 2022 record of 39.9 percent. The de...
Compass Pathways released six-month data from its second Phase 3 trial of COMP360 psilocybin for treatment-resistant depression. Thirty-nine percen...
For four years the press has reported GLP-1 drugs reducing one behavior after another: drinking, smoking, gambling, compulsive shopping, and now vi...
Cambridge tested the first vaccine whose active component was designed entirely by computation. No pathogen was isolated. Machine learning identifi...
Stanford found that 10% of the population carries PAM gene variants that make them resistant to GLP-1 drugs. The resistance is not at the receptor ...